Wordt geladen...
P11.46 Discovery of a new HDAC6 inhibitor for the treatment of glioblastoma
BACKGROUND: Glioblastoma’s origin and development is not only associated to genetic alterations, but also to epigenetic changes. Indeed, an altered expression or activity of epigenetic enzymes such as histone deacetylases (HDAC) has been associated to cancer stem cell activity, which has been widely...
Bewaard in:
| Gepubliceerd in: | Neuro Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6796111/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.192 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|